Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Meagan Spencer Barbee"'
Autor:
Chloe S. Lalonde, Christine C. Davis, Jane L. Meisel, Zhengjia Chen, Meagan Spencer Barbee, Subir Goyal, Jordyn Paige Higgins, Joan L. Kramer, Kandra Horne, Kristina F. Byers
Publikováno v:
Journal of Clinical Oncology. 38:e13085-e13085
e13085 Background: The specifics of the salvage regimen gemcitabine/carboplatin (G/C) in metastatic breast cancer (MBC) are not well-characterized and are limited to the clinical trial setting, which often excludes heavily pretreated patients with hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c69119a1d7dd3dda91a0bc1fe4446cd
https://doi.org/10.1200/jco.2020.38.15_suppl.e13085
https://doi.org/10.1200/jco.2020.38.15_suppl.e13085
Autor:
Kristina Frinzi, Meagan Spencer Barbee, Urvi Patel, Elizabeth Sakach, Zhengjia Chen, Jane L. Meisel
Publikováno v:
Journal of Clinical Oncology. 37:1062-1062
1062 Background: Cyclin-dependent kinase 4/6 inhibitors (CDK 4/6i) are widely used in the treatment of hormone receptor positive, metastatic breast cancer (MBC). CDK 4/6is are well-tolerated and highly effective, but can cause neutropenia. Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8427dbf9d08ebc2d9d78160191055bbc
https://doi.org/10.1200/jco.2019.37.15_suppl.1062
https://doi.org/10.1200/jco.2019.37.15_suppl.1062